• no-js

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases. The Institute benefits from strategic support from the MRC.

MRC logo

The Institute values communication with members of the broader scientific community and the general public and with the support of the Medical Research Council (MRC) we have commissioned three short videos to explain our mission.

News

WIMM PhD students reach the final of international biotech startup competition

WIMM PhD students reach the final of international biotech startup competition

Posted 11/05/2015

Bridging the divide between academia and industry is the sacred goal of many researchers, but few are equipped to take their ideas from the bench to the boardroom. However, OneStart (an initiative supported by the Oxbridge Biotech Roundtable and SR One - the corporate venture capital arm of GSK) is designed to help scientists do just that, and a team of four PhD students from Tudor Fulga’s lab have made it to the final of this year’s hotly ...

 

Henry Wellcome Post-doctoral Fellowship awarded

Henry Wellcome Post-doctoral Fellowship awarded

Posted 29/04/2015

Dr James Felce, of the T-cell Biology Group and the HIU, has been awarded a Henry Wellcome Post-doctoral Fellowship by the Wellcome Trust. The fellowship is for 4 years and James will be working with Prof. Mike Dustin at the Kennedy Institute but also partly at the ETH Zurich. He will be studying the role of G protein-coupled receptors in the regulation of T-cell activation using a number of imaging and microfluidic techniques. James said, ...

 News Archive

 

Vacancies

Postdoctoral Scientist in Leukaemia Biology Ref:118644

Posted 27/05/2015

Project: Acute Myeloid Preleukaemia and Leukaemia in Human Down Syndrome   We are seeking a highly motivated and talented Postdoctoral Scientist to join Professor Paresh Vyas’ research group in the MRC Molecular Haematology Unit (MHU), to work on an exciting project on biology of leukaemia and preleukaemia. Study of leukaemia has provided important general principles in cancer biology and innovative breakthrough treatments in cancer care. ...

Further Vacancies

WIMM Blog

The United Kingdom – the first country to have a detailed map of the genetic distribution of its people

dnawall1
The United Kingdom boasts a colourful history of wars, invasions, and both immigration and emigration of many, many different people. Archaelogists and historians can tell us much about how the Romans, Vikings, Normans and many others impacted the lives of the native Britons who lived here – but how are these historical events reflected in the genetic makeup of the population? Did these conquerors leave a lasting impact on the DNA of the people of the British Isles? Twenty years ago, Sir Walter Bodmer (a group leader at the WIMM) initiated a colossal study to collect DNA from thousands of individuals in the UK to address this very question, and the findings were finally published last month in Nature. Katarzyna Hutnik, a scientist in Sir Bodmer’s lab who was involved in the study, explains more.

WIMM Blog Archive